$MNDYNeutralLow

George James Case sold $161K of MNDY

George James Case (CRO) sold 1,773 shares of monday.com Ltd. (MNDY) at $90.79 ($0.16M total) on 2026-06-02.

6/10
6/10
Low
Neutral
Filed 2026-06-03; sale executed 2026-06-02
Neutral-to-slightly negative (insider selling), but not a clear fundamental catalyst

This is an insider selling disclosure; it may modestly affect sentiment but does not signal a fundamental change by itself.

monday.com’s CRO, George James Case, filed an open-market sale of 1,773 shares at ~$90.79 on 2026-06-02.

Likely limited near-term impact; any effect is typically sentiment-driven and small.

Background

The article is an SEC Form 4 insider transaction disclosure for monday.com (MNDY).

Why it matters

Insider selling can slightly pressure sentiment, but without additional company-specific news it usually has low trading impact.

Market relevance

A single officer sale at ~$90.79/share; potential minor sentiment effect only.

Market effects

No direct sector read-through from a single insider sale disclosure.

None indicated.

None indicated.

Alternative perspectives

Insider selling can reflect diversification or liquidity needs rather than bearish expectations, especially for routine officer transactions.

The sale is not tied to a disclosed 10b5-1 plan in the filing, but the article provides no context on whether other insiders sold/bought or whether the company had concurrent news.

Key entities

  • monday.com Ltd.

    Subject of the Form 4 insider transaction disclosure.

  • George James Case

    CRO who sold 1,773 shares in an open-market transaction.

Related articles

$MNDYLow

monday.com, RingCentral, and BlackLine Shares Plummet, What You Need To Know

monday.com, RingCentral and BlackLine shares fell about 5%–6% in the afternoon as investors took profits after a sharp software rally. The iShares Expanded Tech-Software ETF rose 15% over three sessions and ServiceNow gained nearly 40% in four. The S&P 500 software sector fell ~3.78% while the broader market was mostly flat, indicating sector digestion rather than broad risk-off.

$MNDYLowAI 8/10

monday.com (NASDAQ:MNDY) Shares Gap Up – What’s Next?

monday.com (MNDY) shares opened at $90.54 after closing at $83.62, then last traded at $91.62. Analysts cited mixed views: DA Davidson set $100, BTIG cut to $115 (buy), Jefferies reiterated hold, Wolfe set $95 (outperform), and Canaccord cut to $115 (buy). Consensus target is $126.48. The company reported $1.15 EPS and $351.27M revenue in Q1.

$MNDYMed

OBERNDORF WILLIAM E Dumps 74,000 monday.com Shares in Q1 Exit

According to the article, Oberndorf William E. reduced its monday.com holdings by selling 74,000 shares in Q1. It also cut AUM by 32% over the quarter and trimmed stakes in Sprott Physical Gold Trust, Amazon, and Autodesk, while increasing its Veeva Systems stake by 52%. The piece links the moves to portfolio rebalancing.

$MNDYMed

Does monday.com's Revenue Growth With Softer EPS Expectations Reframe Its Expansion Trade-offs (MNDY)?

monday.com (NASDAQ: MNDY) is set to release its Q1 2026 earnings on May 11, with analysts anticipating revenue growth but a decline in earnings per share, highlighting a tension between expansion and profitability. The company's February 2026 guidance projected Q1 revenue of US$338-340 million and full-year revenue of US$1,452-1,462 million. Investors will be watching the earnings report closely to assess how monday.com is balancing its growth ambitions with cost management, especially concerning high R&D and sales and marketing investments.

$MNDYMed

MONDAY.COM LAWSUIT REMINDER: Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. reminds investors in monday.com (MNDY) that a class action lawsuit has been filed. The lawsuit alleges that monday.com made misleading statements regarding its revenue outlook and growth projections, despite experiencing decelerating customer growth and longer sales cycles. Investors who purchased monday.com stock between September 17, 2025, and February 6, 2026, have until May 11, 2026, to apply to be appointed as lead plaintiff.